• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Characterization and stability of S (-) pantoprazole sodium hydrates].[S(-)泮托拉唑钠水合物的表征与稳定性]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017 Mar 25;46(2):160-166. doi: 10.3785/j.issn.1008-9292.2017.04.07.
2
Solid-state behavior of cromolyn sodium hydrates.色甘酸钠水合物的固态行为。
J Pharm Sci. 1999 Nov;88(11):1191-200. doi: 10.1021/js9900710.
3
Physical characterization of pantoprazole sodium hydrates.泮托拉唑钠水合物的物理特性
Int J Pharm. 2005 Mar 3;291(1-2):59-68. doi: 10.1016/j.ijpharm.2004.07.043. Epub 2004 Dec 29.
4
Physical characterization of nedocromil sodium hydrates.奈多罗米钠水合物的物理特性
J Pharm Sci. 1998 Sep;87(9):1052-61. doi: 10.1021/js980106g.
5
Phase Transitions Involving Channel Hydrates of a New Pharmaceutical Compound.涉及新型药物化合物通道水合物的相转变。
Pharm Res. 2024 Jul;41(7):1533-1541. doi: 10.1007/s11095-024-03724-z. Epub 2024 Jun 13.
6
Solid state interconversion between anhydrous norfloxacin and its hydrates.无水诺氟沙星与其水合物之间的固态相互转化。
J Pharm Sci. 2008 Jan;97(1):473-89. doi: 10.1002/jps.21165.
7
Physicochemical characterization of nedocromil bivalent metal salt hydrates. 1. Nedocromil magnesium.奈多罗米二价金属盐水合物的物理化学特性。1. 奈多罗米镁
J Pharm Sci. 1996 Oct;85(10):1026-34. doi: 10.1021/js9602352.
8
RH-Temperature Stability Diagram of the Dihydrate, β-Anhydrate, and α-Anhydrate Forms of Crystalline Trehalose.结晶海藻糖二水合物、β-一水合物和α-一水合物形态的 RH-温度稳定性图。
J Food Sci. 2019 Jun;84(6):1465-1476. doi: 10.1111/1750-3841.14591. Epub 2019 May 1.
9
The crystalline state of methylene blue: a zoo of hydrates.甲烯蓝的结晶态:水合物的动物园。
Phys Chem Chem Phys. 2012 Jun 14;14(22):8074-82. doi: 10.1039/c2cp40128b. Epub 2012 Apr 5.
10
Formation and Transformation Behavior of Sodium Dehydroacetate Hydrates.脱氢乙酸钠水合物的形成与转化行为
Molecules. 2016 Apr 6;21(4):458. doi: 10.3390/molecules21040458.

本文引用的文献

1
A Retrospective: On Clinical Studies with 5-Fluorouracil.一项回顾性研究:关于5-氟尿嘧啶的临床研究。
Cancer Res. 2016 Feb 15;76(4):767-8. doi: 10.1158/0008-5472.CAN-16-0150.
2
Cocrystal habit engineering to improve drug dissolution and alter derived powder properties.共晶习性工程以改善药物溶解并改变衍生粉末性质。
J Pharm Pharmacol. 2016 May;68(5):665-77. doi: 10.1111/jphp.12476. Epub 2015 Sep 26.
3
Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide.卡马西平与烟酰胺共晶的初始溶解动力学
J Pharm Pharmacol. 2015 Nov;67(11):1512-8. doi: 10.1111/jphp.12461. Epub 2015 Aug 19.
4
Co-crystallization with nicotinamide in two conformations lowers energy but expands volume.与处于两种构象的烟酰胺共结晶会降低能量但增加体积。
J Pharm Sci. 2014 Sep;103(9):2896-2903. doi: 10.1002/jps.23929. Epub 2014 Mar 14.
5
Supramolecular hydrogels made of basic biological building blocks.由基本生物构建块制成的超分子水凝胶。
Chem Asian J. 2014 Jun;9(6):1446-72. doi: 10.1002/asia.201301693. Epub 2014 Mar 12.
6
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.通过晶体工程优化活性药物成分以提高溶解度和溶出速率。
Adv Drug Deliv Rev. 2007 Jul 30;59(7):617-30. doi: 10.1016/j.addr.2007.05.011. Epub 2007 May 29.
7
5-fluorouracil: mechanisms of action and clinical strategies.5-氟尿嘧啶:作用机制与临床策略
Nat Rev Cancer. 2003 May;3(5):330-8. doi: 10.1038/nrc1074.
8
The hydrogen bond in the solid state.固态中的氢键。
Angew Chem Int Ed Engl. 2002 Jan 4;41(1):49-76. doi: 10.1002/1521-3773(20020104)41:1<48::aid-anie48>3.0.co;2-u.
9
Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review.5-氟尿嘧啶的三种口服前体药物(卡培他滨、优福定、S-1)的临床研究:综述
Oncologist. 2002;7(4):288-323. doi: 10.1634/theoncologist.7-4-288.
10
In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil.基于瓜尔胶的5-氟尿嘧啶结肠靶向口服给药系统的体外药物释放研究。
Eur J Pharm Sci. 2002 Aug;16(3):185-92. doi: 10.1016/s0928-0987(02)00081-7.

[S(-)泮托拉唑钠水合物的表征与稳定性]

[Characterization and stability of S (-) pantoprazole sodium hydrates].

作者信息

Bei Chen, Libo Zhang, Hong L I, Guping Tang, Xiurong H U

机构信息

School of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

Hangzhou Huadong Medicine Group Pharmaceutical Research Institute Co., Ltd, Hangzhou 310011, China.

出版信息

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017 Mar 25;46(2):160-166. doi: 10.3785/j.issn.1008-9292.2017.04.07.

DOI:10.3785/j.issn.1008-9292.2017.04.07
PMID:28752707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10397102/
Abstract

To study the characteristics and stability of new S(-) pantoprazole sodium hydrates. The X-ray single crystal diffractometer (SXRD), X-ray powder diffractometer (PXRD), thermogravimetric analysis (TG) and infrared spectrometry (IR) were used to characterize S(-) pantoprazole sodium hydrates. The stability of the hydrates was evaluated by high temperature test,affecting factors test and accelerated test. The crystalline water in S(-) pantoprazole sodium hydrates were very easy to lose and obtain, but crystal structure was not changed significantly. The transition from S(-) pantoprazole sodium trihydrate to S(-) pantoprazole sodium hemipentahydrate occurred at approximately 40 ℃ and reversible transitions from hemipentahydrate to trihydrate occurred at high humidity. Two hydrates had no significant difference in accelerated test. The crystal structure of the two hydrates are almost the same, hemipentahydrate is more stable than trihydrates at high temperature or at exposure to light(at 4500 ± 500 lx).

摘要

研究新型S(-)泮托拉唑钠水合物的特性与稳定性。采用X射线单晶衍射仪(SXRD)、X射线粉末衍射仪(PXRD)、热重分析(TG)和红外光谱(IR)对S(-)泮托拉唑钠水合物进行表征。通过高温试验、影响因素试验和加速试验对水合物的稳定性进行评估。S(-)泮托拉唑钠水合物中的结晶水很容易失去和获得,但晶体结构没有明显变化。S(-)泮托拉唑钠三水合物向S(-)泮托拉唑钠半五水合物的转变大约在40℃发生,在高湿度下从半五水合物到三水合物的转变是可逆的。两种水合物在加速试验中无显著差异。两种水合物的晶体结构几乎相同,在高温或光照(4500±500勒克斯)条件下,半五水合物比三水合物更稳定。